Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in colorectal carcinoma invasion and metastasis

被引:42
|
作者
Li, Bing-Hui [1 ]
Zhao, Peng [1 ]
Liu, Shi-Zheng [1 ]
Yu, Yue-Ming [1 ]
Han, Mei [1 ]
Wen, Jin-Kun [1 ]
机构
[1] Hebei Med Univ, Dept Surg, Hosp 4, Shijiazhuang 050011, Hebei Province, Peoples R China
关键词
Extracellular matrix turnover; Colorectal carcinoma; Metastasis;
D O I
10.3748/wjg.v11.i20.3046
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AIM: To explore the relationship between matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) in the development of colorectal carcinoma and to provide a valuable marker for clinical diagnosis. METHODS: Twenty-five patients with colorectal carcinoma underwent surgical resection. Samples were taken from tumor sites and normal tissues. MMP-2 activity was determined by gelatin zymography. Western blot and ABC immunohistochemical staining were used to detect the expression levels of MMP-2 and TIMP-2 in normal and colorectal carcinoma tissues. Statistical analyses were performed using the Student's ttest and one-way ANOVA. P<0.05 was considered statistically significant. All the statistical analyses were performed using SPSS 10.0 software. RESULTS: MMP-2 activity could be detected in both normal and colorectal carcinoma tissues. MMP-2 activity in colorectal carcinoma tissues was much higher than that in normal tissues (P<0.05, t = 3.916, 4.227). MMP-2 activity was positively related to the colorectal carcinoma invasion depth, lymph node metastasis and Duke's stage. Western blot and ABC immunohistochemical staining demonstrated that the expression level of MMP-2 in colorectal carcinoma tissues was much higher than that in normal tissues (P<0.05, t = 9.429), but the expression level of TIMP-2 in colorectal carcinoma tissues was much lower than that in normal tissues (P<0.05, t = 7.329). The MMP-2/TIMP-2 ratio of colorectal carcinoma was much higher than that of normal tissues. With the progression of invasion depth, lymph node metastasis and tumor Duke's stage, the activity and expression level of MMP-2 and TIMP-2 gradually increased, but the MMP-2/TIMP-2 ratio gradually decreased. CONCLUSION: The balance between MMP-2 and TIMP-2 plays a crucial role in the process of colorectal carcinoma invasion and metastasis. (C) 2005 The WJG Press and Elsevier Inc. All rights reserved.
引用
收藏
页码:3046 / 3050
页数:5
相关论文
共 50 条
  • [2] Prognostic value of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in bladder carcinoma
    Xu, KX
    Hou, SK
    Du, ZJ
    [J]. CHINESE MEDICAL JOURNAL, 2002, 115 (05) : 743 - 745
  • [3] Matrix metalloproteinase-2 regulates the expression of tissue inhibitor of matrix metalloproteinase-2
    Kimura, Kaoru
    Cheng, Xian Wu
    Nakamura, Kae
    Inoue, Aiko
    Hu, Lina
    Song, Haizhen
    Okumura, Kenji
    Iguchi, Akihisa
    Murohara, Toyoaki
    Kuzuya, Masafumi
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2010, 37 (11) : 1096 - 1101
  • [4] Serum metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in lung carcinoma patients
    Drzewiecka-Jedrzejczyk, Magdalena
    Wlazel, Rafal
    Terlecka, Monika
    Jablonski, Slawomir
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (12) : 5306 - 5313
  • [5] Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis
    Kang, Shan
    Zhao, Xiwa
    Xing, Huimin
    Wang, Na
    Zhou, Rongmiao
    Chen, Shucheng
    Li, Wansheng
    Zhao, Jian
    Duan, Yanan
    Sun, Donglan
    Li, Yan
    [J]. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2008, 49 (03) : 226 - 231
  • [6] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [7] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 gene polymorphisms in multiple sclerosis
    Benesova, Y.
    Beranek, M.
    Hladikova, M.
    Vacha, J.
    Kadanka, Z.
    Vasku, A.
    [J]. JOURNAL OF NEUROLOGY, 2007, 254 : 68 - 68
  • [8] Overexpression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in liver from patients with gastrointestinal adenocarcinoma and no detectable metastasis
    Theret, N
    Musso, O
    Campion, JP
    Turlin, B
    Loreal, O
    LHelgoualch, A
    Clement, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (04) : 426 - 432
  • [9] Effects of valsartan on matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in atrial fibrillation patients
    裴晓阳
    潘莹
    颜雯
    胡雪松
    [J]. South China Journal of Cardiology, 2010, 11 (01) : 15 - 19
  • [10] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    [J]. ORAL ONCOLOGY, 2011, 47 : S84 - S84